POLAR gene profile predicts which patients may and may not benefit from radiation therapy after breast-conserving surgery

Patients with invasive breast cancer who had low scores on an investigational gene molecular signature had similar rates of local recurrence whether or not they received adjuvant radiation therapy after breast-conserving surgery, according to results of a meta-analysis presented at the San Antonio Breast Cancer Symposium, held December 6-10, 2022.

Related Keywords

Sweden ,San Antonio ,Texas ,United States ,Canada ,Gothenburg ,Vastra Gotalands Lan ,Swedish ,Per Karlsson ,Emily Henderson ,Sahlgrenska Comprehensive Cancer Center ,Swedish Research Council ,Swedish Cancer Society ,King Gustafv Jubilee Clinic Foundation ,University Of Gothenburg ,San Antonio Breast Cancer Symposium ,Scottish Conservation Trial ,Princess Margaret Hospital ,Discovery Industry Focus ,Exact Sciences ,Breast Cancer ,Dancer ,Radiation Therapy ,Surgery ,Gene ,Ene Expression ,Genomics ,Ncology ,Research ,